Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.85EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.85EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.85ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.66 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.66 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.66 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.66 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.66 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.66 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.66 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.66 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XDECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.493EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.493EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.493ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.493ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.493EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.493EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.493ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.493ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.2 (Beta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.351.2 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.2 (Beta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.351.2 (Beta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.351.2 (Beta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.351.2 (Beta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.351.2 (Beta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.351.2 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.640.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.640.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.640.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.640.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.640.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.640.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.352EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.352EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.352ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.352ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.352EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.352EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used